The Gene Sequencing Market is at the heart of the genomics revolution, offering technologies to rapidly determine the precise order of nucleotides within a $\text{DNA}$ or $\text{RNA}$ molecule. The continuous reduction in sequencing cost and the massive increase in data output have made this technology central to research, diagnostics, and personalized medicine.Gene Sequencing Market.

The market is dominated by Next-Generation Sequencing ($\text{NGS}$) platforms (e.g., Illumina, $\text{Ion}$ Torrent), which utilize massively parallel sequencing to analyze millions of $\text{DNA}$ fragments simultaneously, enabling applications like Whole Genome Sequencing ($\text{WGS}$), Whole Exome Sequencing ($\text{WES}$), and targeted panels. The key trend is the emergence of Third-Generation Sequencing (e.g., Oxford Nanopore, PacBio), offering Long-Read Sequencing capabilities that provide crucial information for resolving complex structural variants and repetitive regions often missed by short-read $\text{NGS}$. The expanding use of $\text{NGS}$ in clinical oncology, non-invasive prenatal testing ($\text{NIPT}$), and infectious disease surveillance is fueling the high-growth trajectory 

Related Reports